Document:

eoss_ex102.htm

EXHIBIT 10.2
  
 經 營 管 理 協 議 書
 Business and Management Agreement
  
 本經營管理協議(以下簡稱「本協議」)由下美商EOS INC.(一設立於美國OTCQB交易市場掛牌之公司,股票代碼:EOSS,以下簡稱「甲方」)及亞視亨國際企業股份有限公司(一依中華民國法律所設立及合法存續之公司,以下簡稱「乙方」,甲方及乙方以下合稱「雙方」)共同簽署。
   
 This Business and Management Agreement (the “Agreement”) is made and entered into by and between EOS Inc., a Nevada corporation (FEIN:30-0873246) trading over OTCMarkets with symbol EOSS (“Party A”), and AsiaSonic International Industrial Co., LTD., a company formed under the laws of Republic of China ( “Party B”). Party A and Party B are collectively referred to as the “Parties”. For valuable considerations exchanged, the Parties have agreed to the following terms and conditions. 
  
 緣,甲方及乙方欲進行一股份交換(以下簡稱「主協議」),甲方擬以其未來所擬定發行之新股壹佰伍拾萬股交換乙方已發行股份總數之百分之五十一之股份;本協議為主協議之一部分,就主協議簽署完成後,甲、乙雙方就如何經營管理乙公司,甲、乙雙方協議共同遵守下列條款。
   
 Whereas, the Parties entered into an Investment Cooperation Agreement (the “Main Agreement”), and Party A will issue 1.5 million new shares in EOS INC. stocks in exchange for the equivalent value of 51% of the total issued shares of Party B; This Agreement is a part of the Main Agreement. After the signing of the Main Agreement, in regards to the business and management of Party B, the Parties agree to abide by the following terms:
   
 	 經營管理協議(商業機密)
	  
	 Page 1 of 6

 	 
	
	

	 

      
 第一條:經營管理協議
  
 Article 1: Business and Management Agreement
   
 	  
	 1. 
	 於甲方、乙方就主協議所進行之股份交換完成後,甲方將持有乙方已發行股份總數百分之五十一之股份,甲方同意乙方原有之經營管理模式,除經董事會決議解任外,由乙方繼續指派乙方公司之負責人及總經理。

	  
	  
	  

	  
	  
	 After the completion of the share exchange between Party A and Party B on the Main Agreement, Party A will hold 51% of the total issued shares of Party B. Party A agrees to Party B’s original business management model, except for dismissal by a resolution of the board of directors. Party B shall continue to appoint the managers and person in charge. 

	  
	  
	  

	  
	 2. 
	 在簽署本協議後,於甲、乙雙方完成簽署股東協議或乙方公司取得新的資本(包括以股權或債權出資)前,甲方得指派至少一名代表席次進入乙方董事會。

	  
	  
	  

	  
	  
	 After signing this Agreement, prior to signing of the Main Agreement or before Party B obtain new capital (including equity or debt contribution), Party A may appoint at least one representative as Party B’s board of directors.

	  
	  
	  

	  
	 3.
	 表決權拘束契約條款:

	  
	  
	  

	  
	  
	 Voting rights binding contract clauses:

   
 	  
	 (1)
	 甲方同意,於甲方持有乙方股份之期間,甲方雖持有乙方公司百分之五十一之股份,但其僅得選任或指派一名董事,且甲方同意其所指派之董事不會競選董事長職位。甲方應要求其所指派之董事,表決權之行使應與乙方所指派之董事相同。

	  
	  
	  

	  
	  
	 Party A agrees that while Party A holds 51% of Party B’s shares, Party A can only elect or appoint one director, and the appointed director will not run for the position of Chief Executive Officer. Party A shall request its appointed director to exercise voting rights in accordance to the voting interests of the directors appointed by Party B.

    
 	 經營管理協議(商業機密) 
	  
	 Page 2 of 6

 	 
	
	

	 

     
 	  
	 (2)
	 甲方同意,於甲方持有乙方股份之期間,甲方於任何股東會或性質相同之會議上,甲方不會提出任何議案。甲方就其所持有之股份,股東表決權之行使應與乙方所指派之董事相同。

	  
	  
	  

	  
	  
	 Party A agrees that during the period when Party A holds Party B’s shares, Party A will not propose any proposals at any shareholder meeting or any other meetings of the same nature. For the shares held by Party A, the exercise of shareholder voting rights shall be in accordance to the voting interests of the directors appointed by Party B.

    
 第二條:生效條件、契約存續期間與優先買回權、解除契約
    
 Article 2: Effective Conditions, Duration of the Contract, Right of First Refusal, and Termination of the Contract
   
 	  
	 1.
	 生效條件:本協議書於簽約日起生效。

	  
	  
	  

	  
	  
	 Effective Conditions: This Agreement will become effective on the date of signing.

	  
	  
	
	  
	 2.
	 契約存續期間與優先買回權:

	  
	  
	  

	  
	  
	 The duration of the contract and the right of first refusal:

   
 	  
	 (1)
	 本協議之簽訂目的係因甲、乙雙方共同為使甲方公司於美國OTCQB交易市場申請轉板至紐約證券交易所(NYSE)上市而共同簽訂;如此一目的達成,本協議之效力存續至甲、乙方任一方公司結束經營、公司遇有重大事故,或甲乙雙方合意終止本協議止。

	  
	  
	  

	  
	  
	 The Parties agreed to the terms of this Agreement for the purpose of Party A to up-list from OTCMarket to the New York Stock Exchange (NYSE); such a purpose is achieved, this Agreement shall remain valid and last until either Parties’ company terminates operations, the company encounters a major accident, or both parties agree to terminate this Agreement.

       
 	 經營管理協議(商業機密) 
	  
	 Page 3 of 6

 	 
	
	

	 

     
 	  
	 (2)
	 如甲方欲轉讓乙方公司之股份,應事先以書面通知乙方其所欲轉讓之股份數、價格及其他條件,且乙方享依相同條件之優先承購權,以取得甲方欲轉讓之全部或一部乙方公司股份。

	  
	  
	  

	  
	  
	 If Party A intends to transfer the shares of Party B’s company, it shall notify Party B in writing of the number of shares it intends to transfer, price and other conditions, and Party B shall enjoy the right of first refusal under the same conditions in order to obtain all or part of the shares which Party A wish to transfer. 

   
 	  
	 3.
	 附條件之解除契約

	  
	  
	
	  
	  
	 Conditional termination of contract

	  
	  
	  

	  
	  
	 如甲、乙雙方就本協議簽訂之目的不復存在,或甲方所欲達成之目標並未達成,即本協議視為解除,甲、乙雙方當事人應將股份回復原狀。

	  
	  
	  

	  
	  
	 If the purpose of the signing of this Agreement by the Parties no longer exists, or the goal that Party A intends to achieve is not achieved, this Agreement is deemed to be cancelled, and both parties shall return the shares to the original state.

   
 第三條:準據法及管轄法院
  
 Article 3: Governing Law and Court of Jurisdiction.
  
 如本協議有未盡事宜,悉依中華民國(台灣)之法律規定辦理。甲、乙雙方因本協議書或違反本協議書引起之糾紛、爭議或歧見,雙方同意先本誠信原則協商之,協商不成而涉訟時,雙方特此同意以臺灣臺北地方法院為第一審管轄法院。
  
 This Agreement shall be governed and construed by the laws of Republic of China (Taiwan). In case of any dispute, claim or disagreement arising in relation to or in connection with is Agreement, parties shall first seek to resolve any such conflict by mediation in good faith; and failing which, the Parties hereby agree to submit the conflict to the Taipei District Court as the court of the first instance. 
       
 	 經營管理協議(商業機密) 
	  
	 Page 4 of 6

 	 
	
	

	 

     
 第四條:效力範圍
  
 Article 4: Severance
  
 本協議書部分條款依法被認為無效時,其他條款仍應繼續有效。
  
 In case any of the provisions hereof shall be deemed invalid by laws, other provisions shall nonetheless continue to take effect. 
  
 第五條:契約份數
  
 Article 5: Counterparts
  
 本協議壹式貳份,由甲乙雙方各執乙份為憑。
  
 This Agreement shall be executed in two identical counterparts and Party A and Party B shall each bear one such counterpart. 
       
 	 經營管理協議(商業機密) 
	  
	 Page 5 of 6

 	 
	
	

	 

     
 立約人:
 Parties:
  
 甲方:EOS INC.
 Party A: EOS INC.
 法定代表人: 楊賀翔 
 Authorized Representative: HE SIANG YANG
 簽名: /s/ He Siang Yang
 Signature: 
 電話:02-25868300
 Tel: 02-25868300
 地址:台北市中山區中山北路2段162號7樓之1
 Address: 7F-1, No.162, Zhongshan N Rd. Section 2, Zhongshan District, Taipei, Taiwan
  
 乙方:亞視亨國際企業股份有限公司
 Party B: AsiaSonic International Industrial Co., LTD. 
 法定代表人: Zhu Fa You
 Authorized Representative: 
 簽名: /s/ Zhu Fa You
 Signature:
 電話:
 Tel:
 地址:新北市新莊區新樹路234巷11號
 Address: No.11, Lane 234, Xin Shu Road, Xinzhuang District, New Taipei City, Taiwan
  
 西元           2021          年          8           月          28          日
      
 	 經營管理協議(商業機密) 
	  
	 Page 6 of 6thct_ex101.htm

EXHIBIT 10.1
    
 SHEFFORD CAPITAL MANAGEMENT, LLC.
  
 THC Therapeutics, Inc.
  
 ENGAGEMENT AGREEMENT
  
 THIS ENGAGEMENT AGREEMENT, (the "Agreement") dated as of the date written below, is by and between Shefford Capital Management, LLC. (the "Advisor") and THC Therapeutics, Inc. (the "Company"),
  
 WHEREAS, the Company desires to retain the Advisor and the Advisor desires to be retained by the Company pursuant to the terms and conditions hereinafter set forth:
  
 NOW, THEREFORE, in consideration of the foregoing and the mutual promises and covenants herein contained, it is hereby agreed as follows:
   
 	 Advisor:
	  
	 Shefford Capital Management, LLC. will be the Company's exclusive accounting and financial advisor ("Advisor").

	  
	  
	  

	 Role:
	  
	 Advisor designates Jonathan Cross to act as the Company's Chief Financial Officer, developing strategy for the Company's and executing said strategy. Mr. Cross will be responsible for financial management and accounting activities, including recapitalizing the company, developing efficient monthly accounting closing processes, reviewing the Company's monthly financial statements and the Company's reporting; liazing with the Company's external accountants on a monthly or quarterly basis and certifying the Company's public financial statements as the Company 's Chief Financial Officer.

	  
	  
	  

	  
	  
	 The Company accepts Jonathan Cross as its Chief Financial Officer.

	  
	  
	  

	 Term:
	  
	 One year commencing August 24, 2021 (the "Term"), with appropriate extensions as agreed to by the Advisor and the Company. Notwithstanding the foregoing, either party may terminate this Agreement upon 30 days' written notice.

	  
	  
	  

	 Compensation:
	  
	 The Advisor shall be compensated as follows:

	  
	  
	  

	  
	  
	 On an ongoing monthly basis over the Term, a fee of $2,000 per month, payable in advance, for performing the services detailed above (under the "Role" section) in those months where a 10K or 10Q SEC financial filing is not required.
  
 In those months where a 10K or 10Q SEC financial filing is required, a fee of $4,000 a month will be paid for performing the services detailed above.
  
 In addition to the cash compensation specified above, the Advisor will be issued stock options over the Term, as follows:

     
 	  
	 ·
	an option to purchase 1,000,000 shares of the Company's common stock, granted on the date below, at an exercise price equal to the closing price of a share of the Company's common stock on the grant date (adjusted for splits), such option to vest in full 90 days after grant; and,
	  
	  
	  

	  
	 ·
	options to purchase 200,000 shares of the Company's common stock per month; each such option to be granted on the last day of each month commencing September 2021 and ending August 2022, provided that this Agreement has not been terminated prior to each such grant date, at an exercise price equal to the closing price of a share of the Company's common stock on each grant date, each such option to be fully vested upon grant.

    
 	 
	
	

	 

   
 	 Expenses:
	  
	 Company will pay, or cause to be paid, directly, or reimburse the Advisor for, their Out-of-Pocket Expenses (as defined below). For the purposes of this Agreement, the term "Out-of-Pocket Expenses" means the out-of-pocket costs and expenses incurred by the Advisor in connection with its Role or other services provided under this Agreement, including: business publications, on-line financial services, or similar services, retained or used by the Advisor and costs of any transportation, lodging, or any similar expense associated with services provided to the Company. All payments or reimbursements for Out-of-Pocket Expenses will be made by wire transfer in same-day funds promptly upon or as soon as practicable following request for payment or reimbursement in accordance with this Agreement, to the bank account indicated to the Company by the Advisor.

	  
	  
	  

	 Indemnification:
	  
	 Customary indemnification normally accorded to accounting and financial advisors shall hold harmless the Advisor from any losses, claims or damages resulting from the Advisor's services, except as delineated in the Chief Financial Officer Certification requirements of the Sarbanes Oxley Act. A separate indemnification agreement shall be executed in a form satisfactory to the Advisor.

	  
	  
	  

	  
	  
	 In the event the Advisor is called to testify, provide legal support or be a witness on behalf of the Company for any event at any time, all legal expenses and professional time will be reimbursed by the Company.

	  
	  
	  

	 Arbitration:
	  
	 Any dispute between the Advisor and the Company regarding the construction or application of the Agreement and the related services will, upon a written request, be submitted to arbitration, and this arbitration shall comply with and be governed by the provisions of the American Arbitration Association and shall take place in New York, New York. The prevailing party shall be entitled to attorney fees and costs incurred in connection with any such dispute.

	  
	  
	  

	 Governing Law:
	  
	 This Agreement shall be governed by the laws of the State of New York.

    
 AGREED TO AND ACCEPTED THIS 24 DAY OF AUGUST 2021.
    
 	Shefford Capital Management, LLC.	 	THC Therapeutics, Inc. 	 
	  
	  
	  
	  

	 477 Madison Avenue
 Sixth Floor
 New York, New York 10022
	  
	 11700 W Charleston Boulevard 
  #73
 Las Vegas, Nevada 89135
	  

	  
	  
	  
	  

	 /s/ Jonathan Cross 
	 	 /s/ Brandon Romanek
	 
	 Jonathan Cross
	 	 Brandon Romanek 
	 
	 Managing Director
	 	CEO	 

    
 	  
	2
	

	 

    
 SHEFFORD CAPITAL MANAGEMENT, LLC.
 Scope Letter 
  
 The scope of the Engagement Agreement (the "Agreement") dated as of August 24, 2021, by and between Shefford Capital Management, LLC. (the "Advisor") and THC Therapeutics, Inc. (the "Company") is limited to the details herein. The tasks to be performed as delineated herein are to be completed within the term of the Agreement. The scope of the Agreement may only be modified by written consent of both the Advisor and the Company.
  
 The tasks are as follows:
  
 	 1.
	 Collaborate with the Company's CEO to develop, capitalize and execute the Company's Buy-and-Build strategy.

	  
	  

	 2.
	 Review and establish the Company's monthly accounting closing process for the timely production of financial statements.

	  
	  

	 3.
	 Specific additional activities shall include but not be limited to:

     
 	  
	 A.
	 Review and implement production of the Company's monthly financial statements and quarterly and annual reporting on Forms 10Q and 10K, respectively.

	  
	  
	  

	  
	 B.
	 Establish other financial and accounting processes, if requested, such as budgeting, forecasting and the development of operating metrics.

	  
	  
	  

	  
	 C.
	 Act as the liaison with the Company's external accountants and the Audit Committee of the Board of Directors.

	  
	  
	  

	  
	 D.
	 Certify the Company's public financial statements as the Company's Chief Financial Officer.

	  
	  
	  

	  
	 E.
	 Transition to a permanent Chief Financial Officer, at the appropriate time.

	  
	  
	  

	  
	 F.
	 Assistance with the design and implementation of internal controls in accordance with the requirements of the Sarbanes-Oxley Act of 2002, as amended, and the rules and regulations of the Securities and Exchange Commission and the various stock exchanges applicable to the Company.

    
 AGREED TO AND ACCEPTED THIS 24 DAY OF AUGUST 2021.
    
 	 Shefford Capital Management, LLC.
	  

	  
	  

	 /s/ Jonathan Cross
	  

	 Jonathan Cross
	  

	 Managing Director
	  

	  
	  

	 THC Therapeutics, Inc. 
	  

	  
	  

	 /s/ Brandon Romanek
	  

	 Brandon Romanek
	  

	 CEO
	  

   
 	 
	3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00333-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00333-of-00352.parquet"}]]